MedTrace Logo

The Role of Dendritic Cells in Hepatitis C Infection

NCT00723242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-07-28

No results posted yet for this study

Summary

The role of the dendritic cells, the most potent antigen presenting cells, in the establishment of chronic hepatitis C is not established. The study aims to define whether the dendritic cells are affected by the hepatitis C virus and whether that bears an impact on the antiviral immune response they generate. The hypothesis is explored by investigating a group of patients prior to and after the initiation of standard treatment for hepatitis C with pegylated Interferon and Ribavirin.

Conditions

  • Chronic Hepatitis C Infection

Interventions

DRUG

Viraferon-peg and Rebetol

Sponsors & Collaborators

  • Schering-Plough

    collaborator INDUSTRY

  • University College, London

    lead OTHER

Study Design

Purpose
BASIC_SCIENCE

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-04-30
Primary Completion
2004-12-31
Completion
2004-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00723242 on ClinicalTrials.gov